Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response.

Wolkowitz OM, Mellon SH, Epel ES, Lin J, Reus VI, Rosser R, Burke H, Compagnone M, Nelson JC, Dhabhar FS, Blackburn EH.

Mol Psychiatry. 2012 Feb;17(2):164-72. doi: 10.1038/mp.2010.133. Epub 2011 Jan 18.

2.

Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder.

Soeiro-de-Souza MG, Teixeira AL, Mateo EC, Zanetti MV, Rodrigues FG, de Paula VJ, Bezerra JF, Moreno RA, Gattaz WF, Machado-Vieira R.

Eur Neuropsychopharmacol. 2014 Jul;24(7):1139-43. doi: 10.1016/j.euroneuro.2014.03.005. Epub 2014 Mar 27.

PMID:
24731723
3.

PBMC telomerase activity, but not leukocyte telomere length, correlates with hippocampal volume in major depression.

Wolkowitz OM, Mellon SH, Lindqvist D, Epel ES, Blackburn EH, Lin J, Reus VI, Burke H, Rosser R, Mahan L, Mackin S, Yang T, Weiner M, Mueller S.

Psychiatry Res. 2015 Apr 30;232(1):58-64. doi: 10.1016/j.pscychresns.2015.01.007. Epub 2015 Jan 19.

4.

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, Ruberto A, Tatarelli R, Nicoletti F, Girardi P, Shelton RC.

J Psychiatr Res. 2009 Jan;43(3):247-54. doi: 10.1016/j.jpsychires.2008.03.014. Epub 2008 Jun 3.

5.

Adverse childhood experiences and leukocyte telomere maintenance in depressed and healthy adults.

Chen SH, Epel ES, Mellon SH, Lin J, Reus VI, Rosser R, Kupferman E, Burke H, Mahan L, Blackburn EH, Wolkowitz OM.

J Affect Disord. 2014 Dec;169:86-90. doi: 10.1016/j.jad.2014.07.035. Epub 2014 Aug 5.

6.

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.

Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ.

J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu.

PMID:
20193645
7.

Serum BDNF levels before treatment predict SSRI response in depression.

Wolkowitz OM, Wolf J, Shelly W, Rosser R, Burke HM, Lerner GK, Reus VI, Nelson JC, Epel ES, Mellon SH.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1623-30. doi: 10.1016/j.pnpbp.2011.06.013. Epub 2011 Jul 3.

8.

Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.

Bot M, Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Mann DL.

J Psychosom Res. 2011 Jul;71(1):13-7. doi: 10.1016/j.jpsychores.2010.11.006. Epub 2011 Jan 15.

9.

Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.

van Calker D, Zobel I, Dykierek P, Deimel CM, Kech S, Lieb K, Berger M, Schramm E.

J Affect Disord. 2009 Apr;114(1-3):243-53. doi: 10.1016/j.jad.2008.07.023. Epub 2008 Oct 11.

PMID:
18849079
10.

Behavioural activation v. antidepressant medication for treating depression in Iran: randomised trial.

Moradveisi L, Huibers MJ, Renner F, Arasteh M, Arntz A.

Br J Psychiatry. 2013 Mar;202(3):204-11. doi: 10.1192/bjp.bp.112.113696. Epub 2013 Feb 7.

PMID:
23391727
11.

Baseline severity of depression predicts antidepressant drug response relative to escitalopram.

Kilts CD, Wade AG, Andersen HF, Schlaepfer TE.

Expert Opin Pharmacother. 2009 Apr;10(6):927-36. doi: 10.1517/14656560902849258 .

PMID:
19317630
12.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
13.

Sertraline and rapid eye movement sleep without atonia: an 8-week, open-label study of depressed patients.

Zhang B, Hao Y, Jia F, Tang Y, Li X, Liu W, Arnulf I.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:85-92. doi: 10.1016/j.pnpbp.2013.08.010. Epub 2013 Aug 29.

PMID:
23994660
14.

Antidepressant treatment of melancholia in older adults.

Sneed JR, Reinlieb ME, Rutherford BR, Miyazaki M, Fitzsimons L, Turret N, Pelton GH, Devanand DP, Sackeim HA, Roose SP.

Am J Geriatr Psychiatry. 2014 Jan;22(1):46-52. doi: 10.1016/j.jagp.2013.02.001. Epub 2013 Oct 8.

PMID:
24119858
15.

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS.

JAMA. 2009 Oct 21;302(15):1651-7. doi: 10.1001/jama.2009.1487.

16.

Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.

Gorgulu Y, Caliyurt O.

Brain Res Bull. 2009 Sep 28;80(3):158-62. doi: 10.1016/j.brainresbull.2009.06.016. Epub 2009 Jul 1.

PMID:
19576267
17.

Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

Eker SS, Kirli S, Akkaya C, Cangur S, Sarandol A.

World J Biol Psychiatry. 2009;10(4 Pt 2):400-8. doi: 10.1080/15622970903131886.

PMID:
19670086
18.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
19.

Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression.

Joaquim HP, Talib LL, Forlenza OV, Diniz BS, Gattaz WF.

J Psychiatr Res. 2012 Aug;46(8):1053-8. doi: 10.1016/j.jpsychires.2012.04.020. Epub 2012 May 22.

PMID:
22622071

Supplemental Content

Support Center